Marrone Bio Innov (MBII)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2012 | 12-2011 | |
| Assets | ||
| Current Assets | ||
| Cash & Cash Equivalents | N/A | 2,210 |
| Marketable Securities | N/A | 2,000 |
| Receivables | N/A | 440 |
| Inventories | N/A | 3,240 |
| Other current assets | 0 | 340 |
| TOTAL | $N/A | $8,230 |
| Non-Current Assets | ||
| PPE Net | N/A | 2,490 |
| Other Non-Current Assets | 0 | 510 |
| TOTAL | $N/A | $3,000 |
| Total Assets | $N/A | $9,810 |
| Liabilities | ||
| Current Liabilities | ||
| Short Term Debt | N/A | 210 |
| Accounts payable and accrued liabilities | 0 | 930 |
| Accrued Expenses | N/A | 1,670 |
| Other current liabilities | N/A | 200 |
| TOTAL | $N/A | $3,200 |
| Non-Current Liabilities | ||
| Long Term Debt | N/A | 290 |
| Other Non-Current Liabilities | 0 | 80 |
| TOTAL | $N/A | $1,080 |
| Total Liabilities | $N/A | $4,300 |
| Shareholders' Equity | ||
| Retained earnings | N/A | -34,730 |
| Other shareholders' equity | 0 | 39,610 |
| TOTAL | $N/A | $5,510 |
| Total Liabilities And Equity | $0 | $9,810 |